首页 文献索引 SCI期刊 AI助手
登录 注册
首页 正文

Review Bone marrow transplantation. 2022 Jun;57(6):857-865. doi: 10.1038/s41409-022-01649-y Q24.52024

The role of JAK inhibitors in hematopoietic cell transplantation

jak抑制剂在造血细胞移植中的作用 翻译改进

Rachel B Salit  1  2

作者单位 +展开

作者单位

  • 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. rsalit@fredhutch.org.
  • 2 Department of Medicine, University of Washington Medical Center, Seattle, WA, USA. rsalit@fredhutch.org.
  • DOI: 10.1038/s41409-022-01649-y PMID: 35388118

    摘要 Ai翻译

    The Janus Kinase (JAK)/Signal Transducers and Activators of Transcription (STAT) pathway is essential for both the regulation of hematopoiesis and the control of inflammation. Disruption of this pathway can lead to inflammatory and malignant disease processes. JAK inhibitors, designed to control the downstream effects of pro-inflammatory and pro-angiogenic cytokines, have been successfully used in pre-clinical models and clinical studies of patients with autoimmune diseases, hematologic malignancies, and the hematopoietic cell transplantation (HCT) complication graft versus host disease (GVHD). In the last decade, JAK inhibitors Ruxolitinib, Fedratinib, and most recently Pacritinib have been United States Federal Drug Administration (FDA) approved for the treatment of myelofibrosis (MF). Ruxolitinib was also recently approved for the treatment of steroid refractory acute as well as chronic GVHD; JAK inhibitors are currently under evaluation in the pre-HCT setting in MF and for the prevention of GVHD. This review will focus on the role of JAK inhibitors in the treatment of hematologic malignancies, the potential function of pre-HCT JAK inhibitors in patients with MF, and the role of JAK inhibitors in the prevention and treatment of acute and chronic GVHD.

    Keywords:JAK inhibitors

    Copyright © Bone marrow transplantation. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Bone marrow transplantation

    缩写:BONE MARROW TRANSPL

    ISSN:0268-3369

    e-ISSN:1476-5365

    IF/分区:4.5/Q2

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    The role of JAK inhibitors in hematopoietic cell transplantation